Hemab Therapeutics Holdings, Inc. (COAG) stock
COAGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026
$39.15+0.09 (+0.23%)
Close on Nov 18, 2026Market cap $1.83BP/E –Yield –
Hemab Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
No market cap figures for Hemab Therapeutics
Hemab Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?